Back

FLECA-ED trial. Flecainide for acute atrial fibrillation cardioversion in ischemic heart disease

14 April 2026 (10:45 - 10:55)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Science: ablation and drug therapy Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Panagiotis K Tsioufis

Hippokration General Hospital, Athens (Greece)

11 More presentations in this session

Presentation thumbnail
Discussant review - FLECA-ED
Professor M. Rienstra (Groningen, NL)
Slides Video
Presentation thumbnail
Discussion - FLECA-ED
Video
Presentation thumbnail
BIO-LIBRA study
Professor V. Kutyifa (Rochester, US)
Slides Video
Presentation thumbnail
Discussant review - BIO-LIBRA
Professor J. Merino (Madrid, ES)
Slides Video
Presentation thumbnail
Discussion - BIO-LIBRA
Video

Access the full session

Session thumbnail
Late-Breaking Science: ablation and drug therapy
Video

The Event

Event poster

EHRA 2026

14 April 2026 10:45 CET
You may be interested in
thumbnail
Congress Session
Late-Breaking Science: ablation and drug therapy
thumbnail
Congress Presentation
Discussant review - FLECA-ED
thumbnail
Congress Presentation
Safety and efficacy of the use of intravenous flecainide in the context of an aggressive rhythm control strategy in patients with atrial fibrillation in the emergency department (HEROMEDICUS study)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources